Tenax Therapeutics Announces Successful Comparative Pharmacokinetic Study of TNX-201 for the Treatment of Pulmonary Arterial Hypertension
Stock Information for Tenax Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.